Search

Author/Creator King, Christopher L

3. Association of Cytomegalovirus Serostatus With Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responsiveness in Nursing Home Residents and Healthcare Workers. (4th February 2023)

Authors:
Freeman, Michael L; Oyebanji, Oladayo A; Moisi, Daniela; Payne, Michael; Sheehan, Maegan L; Balazs, Alejandro B; Bosch, Jürgen; King, Christopher L; Gravenstein, Stefan; Lederman, Michael M; Canaday, David H
Journal:
Open forum infectious diseases
Issue:
Volume 10:Number 2(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Changes in Cytokine, Filarial Antigen, and DNA Levels Associated With Adverse Events Following Treatment of Lymphatic Filariasis. (15th November 2017)

Authors:
Andersen, Britt J; Kumar, Jessica; Curtis, Kurt; Sanuku, Nelly; Satofan, Samson; King, Christopher L; Fischer, Peter U; Weil, Gary J
Journal:
Journal of infectious diseases
Issue:
Volume 217:Number 2(2018)
Page Start:
280
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Comparison of Repeated Doses of Ivermectin Versus Ivermectin Plus Albendazole for the Treatment of Onchocerciasis: A Randomized, Open-label, Clinical Trial. (19th September 2019)

Authors:
Batsa Debrah, Linda; Klarmann-Schulz, Ute; Osei-Mensah, Jubin; Dubben, Bettina; Fischer, Kerstin; Mubarik, Yusif; Ayisi-Boateng, Nana Kwame; Ricchiuto, Arcangelo; Fimmers, Rolf; Konadu, Peter; Nadal, Jennifer; Gruetzmacher, Barbara; Weil, Gary; Kazura, James W; King, Christopher L; Debrah, Alexan...
Journal:
Clinical infectious diseases
Issue:
Volume 71:Number 4(2020)
Page Start:
933
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Efficacy and Safety of a Single Dose of Ivermectin, Diethylcarbamazine, and Albendazole for Treatment of Lymphatic Filariasis in Côte d'Ivoire: An Open-label Randomized Controlled Trial. (23rd October 2019)

Authors:
Bjerum, Catherine M; Ouattara, Allassane F; Aboulaye, Méité; Kouadio, Olivier; Marius, Vanga K; Andersen, Britt J; Weil, Gary J; Koudou, Benjamin G; King, Christopher L
Journal:
Clinical infectious diseases
Issue:
Volume 71:Number 7(2020)
Page Start:
e68
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Identification and Immunological Characterization of the Ligand Domain of Plasmodium vivax Reticulocyte Binding Protein 1a. (7th May 2018)

Authors:
Ntumngia, Francis B; Thomson-Luque, Richard; Galusic, Sandra; Frato, Gabriel; Frischmann, Sarah; Peabody, David S; Chackerian, Bryce; Ferreira, Marcelo U; King, Christopher L; Adams, John H
Journal:
Journal of infectious diseases
Issue:
Volume 218:Number 7(2018)
Page Start:
1110
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Individual Efficacy and Community Impact of Ivermectin, Diethylcarbamazine, and Albendazole Mass Drug Administration for Lymphatic Filariasis Control in Fiji: A Cluster Randomized Trial. (17th March 2021)

Authors:
Hardy, Myra; Samuela, Josaia; Kama, Mike; Tuicakau, Meciusela; Romani, Lucia; Whitfeld, Margot J; King, Christopher L; Weil, Gary J; Grobler, Anneke C; Robinson, Leanne J; Kaldor, John M; Steer, Andrew C
Journal:
Clinical infectious diseases
Issue:
Volume 73:Number 6(2021)
Page Start:
994
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗